about
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its recepto...
Read More
0.99
-0.04
(-3.88%)
193.4K
XNAS Volume
XNAS 23 Jan, 2026 12:29 PM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
InflaRx N.V. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..